| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.04 |